{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:46:14Z","timestamp":1790721974578,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009234","name":"Centralsjukhuset Kristianstad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009234","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional research support, Region Sk\u00e5ne","award":["2022-1284"],"award-info":[{"award-number":["2022-1284"]}]},{"name":"Government funding of clinical research within the Swedish National Health Service","award":["2022:YF0009 and 2022-0075"],"award-info":[{"award-number":["2022:YF0009 and 2022-0075"]}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","award":["2021-0833"],"award-info":[{"award-number":["2021-0833"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lions Sk\u00e5ne research grants"},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5nes universitetssjukhus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2022-0352"],"award-info":[{"award-number":["2022-0352"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["2022-0458"],"award-info":[{"award-number":["2022-0458"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional research support, Region Sk\u00e5ne"},{"name":"Government funding of clinical research within the Swedish National Health Service","award":["2022-0226"],"award-info":[{"award-number":["2022-0226"]}]},{"name":"Government funding of clinical research within the Swedish National Health Service","award":["2021-10233"],"award-info":[{"award-number":["2021-10233"]}]},{"DOI":"10.13039\/501100017237","name":"Hans-Gabriel och Alice Trolle-Wachtmeisters stiftelse f\u00f6r medicinsk forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Critical COVID-19 is associated with high mortality, and acute kidney injury (AKI) is common. Endostatin has emerged as a promising prognostic biomarker for predicting AKI and mortality in intensive care. This study aimed to investigate plasma endostatin at intensive care unit (ICU) admission as a biomarker for AKI, renal replacement therapy (RRT), and 90-day mortality in COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A pre-planned retrospective analysis of a prospectively collected cohort of admissions with a primary SARS-CoV-2 infection to six ICUs in southern Sweden between May 2020 and May 2021 was undertaken. Endostatin at ICU admission was evaluated with multivariable logistic regression analyses adjusted for age, sex, C-reactive protein, and creatinine. Net reclassification index analyses were also performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Four hundred eighty-four patients were included. Endostatin showed a non-linear association with AKI, RRT, and 90-day mortality. Endostatin levels of 100\u2013200 ng\/mL were associated with AKI on ICU day 1 (OR 5.1, 95% CI 1.5\u201318,<jats:italic> p<\/jats:italic>\u00a0=\u00a00.0097), RRT during the ICU stay (OR 3.5, 95% CI 1.1\u201312,<jats:italic> p<\/jats:italic>\u00a0=\u00a00.039), and 90-day mortality (OR 4.2, 95% CI 1.6\u201311,<jats:italic> p<\/jats:italic>\u00a0=\u00a00.0037). Adding endostatin to creatinine improved prediction of AKI on ICU day 1, while adding it to a model containing age, sex, CRP, and creatinine improved prediction of both AKI on ICU day 1 and 90-day mortality, but not RRT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Endostatin at ICU admission was independently associated with AKI, RRT, and 90-day mortality in ICU patients with COVID-19. In addition, endostatin improved the prediction of AKI and 90-day mortality, highlighting its potential as a biomarker for early risk stratification in intensive care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40635-025-00748-6","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:52:38Z","timestamp":1743763958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma endostatin at intensive care admission is independently associated with acute kidney injury, dialysis, and mortality in COVID-19"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-3524","authenticated-orcid":false,"given":"Hazem","family":"Koozi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Zwawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sp\u00e5ngfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Didriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Frigyesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"4","key":"748_CR1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/anae.15425","volume":"76","author":"RA Armstrong","year":"2021","unstructured":"Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM (2021) Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia 76(4):537\u2013548","journal-title":"Anaesthesia"},{"key":"748_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-020-02169-x","volume":"22","author":"Z Xu","year":"2021","unstructured":"Xu Z, Tang Y, Huang Q, Fu S, Li X, Lin B et al (2021) Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19. BMC Nephrol 22:1\u201310","journal-title":"BMC Nephrol"},{"issue":"1","key":"748_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2020060897","volume":"32","author":"S Gupta","year":"2021","unstructured":"Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS et al (2021) AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol 32(1):161\u2013176","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"748_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","volume":"48","author":"VS Vaidya","year":"2008","unstructured":"Vaidya VS, Ferguson MA, Bonventre JV (2008) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48(1):463\u2013493","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"748_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277\u2013285","journal-title":"Cell"},{"issue":"7","key":"748_CR6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1096\/fj.04-2134rev","volume":"19","author":"AG Marneros","year":"2005","unstructured":"Marneros AG, Olsen BR (2005) Physiological role of collagen XVIII and endostatin. FASEB J 19(7):716\u2013728","journal-title":"FASEB J"},{"issue":"6","key":"748_CR7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/HYPERTENSIONAHA.113.02250","volume":"62","author":"AC Carlsson","year":"2013","unstructured":"Carlsson AC, Ruge T, Sundstr\u00f6m J, Ingelsson E, Larsson A, Lind L et al (2013) Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension 62(6):1146\u20131151","journal-title":"Hypertension"},{"issue":"2","key":"748_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/eci.12197","volume":"44","author":"G Gouya","year":"2014","unstructured":"Gouya G, Siller-Matula JM, Fritzer-Szekeres M, Neuhold S, Storka A, Neuhofer LM et al (2014) Association of endostatin with mortality in patients with chronic heart failure. Eur J Clin Invest 44(2):125\u2013135","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"748_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201409-1742OC","volume":"191","author":"R Damico","year":"2015","unstructured":"Damico R, Kolb TM, Valera L, Wang L, Housten T, Tedford RJ et al (2015) Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med 191(2):208\u2013218","journal-title":"Am J Respir Crit Care Med"},{"key":"748_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/COPD.S234760","volume":"15","author":"Y Wu","year":"2020","unstructured":"Wu Y, Qin J, He J, Shen Y, Wang H, Li Y et al (2020) Serum endostatin is a novel marker for COPD associated with lower lung function, exacerbation and systemic inflammation. Int J Chron Obstruct Pulmon Dis 15:397\u2013407","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"748_CR11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000518221","volume":"7","author":"M Li","year":"2021","unstructured":"Li M, Popovic Z, Chu C, Kr\u00e4mer BK, Hocher B (2021) Endostatin in renal and cardiovascular diseases. Kidney Dis 7(6):468\u2013481","journal-title":"Kidney Dis"},{"issue":"16","key":"748_CR12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/bmm-2021-0111","volume":"15","author":"S Asif","year":"2021","unstructured":"Asif S, Ruge T, Larsson A, Anderberg SB, Lipcsey M, Frithiof R et al (2021) Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure. Biomark Med 15(16):1509\u20131517","journal-title":"Biomark Med"},{"key":"748_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-016-0108-x","volume":"6","author":"J M\u00e5rtensson","year":"2016","unstructured":"M\u00e5rtensson J, Jonsson N, Glassford NJ, Bell M, Martling CR, Bellomo R et al (2016) Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients. Ann Intensive Care 6:1\u20139","journal-title":"Ann Intensive Care"},{"issue":"7","key":"748_CR14","first-page":"030006052094085","volume":"48","author":"HM Jia","year":"2020","unstructured":"Jia HM, Zheng Y, Han Y, Ma WL, Jiang YJ, Zheng X et al (2020) Prognostic value of dynamic plasma endostatin for the prediction of mortality in acute kidney injury: a prospective cohort study. J Int Med Res 48(7):0300060520940856","journal-title":"J Int Med Res"},{"issue":"11","key":"748_CR15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/biomedicines9111603","volume":"9","author":"T Ruge","year":"2021","unstructured":"Ruge T, Larsson A, Lipcsey M, Johansson J, Eriksson M (2021) A comparison between endostatin and conventional biomarkers on 30-day mortality and renal replacement therapy in unselected intensive care patients. Biomedicines 9(11):1603","journal-title":"Biomedicines"},{"key":"748_CR16","first-page":"23078","volume":"120","author":"A Frigyesi","year":"2023","unstructured":"Frigyesi A, Lengquist M, Johnsson P, Lybeck A, Sp\u00e5ngfors M, Helena L et al (2023) The Swecrit Biobank, associated clinical registries, and machine learning (artificial intelligence) improve critical care knowledge. Lakartidningen 120:23078","journal-title":"Lakartidningen"},{"issue":"3","key":"748_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/aas.14184","volume":"67","author":"I Didriksson","year":"2023","unstructured":"Didriksson I, Leffler M, Sp\u00e5ngfors M, Lindberg S, Reepalu A, Nilsson A et al (2023) Intensive care unit burden is associated with increased mortality in critically ill COVID-19 patients. Acta Anaesthesiol Scand 67(3):329\u2013338","journal-title":"Acta Anaesthesiol Scand"},{"key":"748_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:1\u201315","journal-title":"Crit Care"},{"key":"748_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 12 Mar 2024."},{"key":"748_CR20","volume-title":"Local regression models","author":"WS Cleveland","year":"1992","unstructured":"Cleveland WS, Grosse E, Shyu WM (1992) Local regression models. Wadsworth & Brooks\/Cole Advanced Books & Software, Monterey"},{"issue":"11","key":"748_CR21","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/ATVBAHA.113.301704","volume":"33","author":"J \u00c4rnl\u00f6v","year":"2013","unstructured":"\u00c4rnl\u00f6v J, Ruge T, Ingelsson E, Larsson A, Sundstr\u00f6m J, Lind L (2013) Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts. Arterioscler Thromb Vasc Biol 33(11):2689\u20132695","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"748_CR22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/aas.12988","volume":"61","author":"J M\u00e5rtensson","year":"2017","unstructured":"M\u00e5rtensson J, Vaara S, Pettil\u00e4 V, Ala-Kokko T, Karlsson S, Inkinen O et al (2017) Assessment of plasma endostatin to predict acute kidney injury in critically ill patients. Acta Anaesthesiol Scand 61(10):1286\u20131295","journal-title":"Acta Anaesthesiol Scand"},{"key":"748_CR23","doi-asserted-by":"crossref","first-page":"1188079","DOI":"10.3389\/fimmu.2023.1188079","volume":"14","author":"K Jandl","year":"2023","unstructured":"Jandl K, Berg JL, Birnhuber A, Fliesser E, Borek I, Seeliger B et al (2023) Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome. Front Immunol 14:1188079","journal-title":"Front Immunol"},{"issue":"11","key":"748_CR24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","volume":"17","author":"M Legrand","year":"2021","unstructured":"Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K et al (2021) Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 17(11):751\u2013764","journal-title":"Nat Rev Nephrol"},{"issue":"100883","key":"748_CR25","volume":"12","author":"I Wijaya","year":"2021","unstructured":"Wijaya I, Andhika R, Huang I, Purwiga A, Budiman KY (2021) The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis. Clin Epidemiol Glob Health 12(100883):100883","journal-title":"Clin Epidemiol Glob Health"},{"issue":"23","key":"748_CR26","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1158\/0008-5472.CAN-05-2617","volume":"65","author":"I Celik","year":"2005","unstructured":"Celik I, S\u00fcr\u00fcc\u00fc O, Dietz C, Heymach JV, Force J, H\u00f6schele I et al (2005) Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res 65(23):11044\u201311050","journal-title":"Cancer Res"},{"issue":"1 Pt 1","key":"748_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-0736-3","volume":"10","author":"DW Davis","year":"2004","unstructured":"Davis DW, Shen Y, Mullani NA, Wen S, Herbst RS, O\u2019Reilly M et al (2004) Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors. Clin Cancer Res 10(1 Pt 1):33\u201342","journal-title":"Clin Cancer Res"},{"key":"748_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.matbio.2021.11.003","volume":"105","author":"K Jandl","year":"2022","unstructured":"Jandl K, Mutgan AC, Eller K, Schaefer L, Kwapiszewska G (2022) The basement membrane in the cross-roads between the lung and kidney. Matrix Biol 105:31\u201352","journal-title":"Matrix Biol"},{"issue":"2","key":"748_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1247\/csf.25.97","volume":"25","author":"UK Zatterstrom","year":"2000","unstructured":"Zatterstrom UK, Felbor U, Fukai N, Olsen BR (2000) Collagen XVIII\/endostatin structure and functional role in angiogenesis. Cell Struct Funct 25(2):97\u2013101","journal-title":"Cell Struct Funct"},{"issue":"4","key":"748_CR30","volume":"4","author":"L Jia","year":"2009","unstructured":"Jia L, Zhang L, Shao C, Song E, Sun W, Li M et al (2009) An attempt to understand kidney\u2019s protein handling function by comparing plasma and urine proteomes. PLoS ONE 4(4):e5146","journal-title":"PLoS ONE"},{"issue":"4","key":"748_CR31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000336109","volume":"35","author":"J Chen","year":"2012","unstructured":"Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS et al (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35(4):335\u2013340","journal-title":"Am J Nephrol"},{"issue":"5","key":"748_CR32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1440-1797.2007.00850.x","volume":"12","author":"M Bellini","year":"2007","unstructured":"Bellini M, Coutinho E, Filgueiras T, Maciel T, Schor N (2007) Endostatin expression in the murine model of ischaemia\/reperfusion-induced acute renal failure. Nephrology 12(5):459","journal-title":"Nephrology"},{"issue":"5","key":"748_CR33","first-page":"753","volume":"21","author":"TT Maciel","year":"2008","unstructured":"Maciel TT, Coutinho EL, Soares D, Achar E, Schor N, Bellini MH (2008) Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model. J Nephrol 21(5):753\u2013760","journal-title":"J Nephrol"},{"issue":"12","key":"748_CR34","doi-asserted-by":"crossref","first-page":"H1692","DOI":"10.1152\/ajpheart.00064.2014","volume":"306","author":"CHS Lin","year":"2014","unstructured":"Lin CHS, Chen J, Ziman B, Marshall S, Maizel J, Goligorsky MS (2014) Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy? Am J Physiol Heart Circ Physiols 306(12):H1692\u2013H1699","journal-title":"Am J Physiol Heart Circ Physiols"},{"issue":"3","key":"748_CR35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1681\/ASN.2008070669","volume":"20","author":"SS Waikar","year":"2009","unstructured":"Waikar SS, Bonventre JV (2009) Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 20(3):672\u2013679","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"748_CR36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-021-00410-w","volume":"17","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Ronco C, Bellomo R (2021) Conceptual advances and evolving terminology in acute kidney disease. Nat Rev Nephrol 17(7):493\u2013502","journal-title":"Nat Rev Nephrol"},{"key":"748_CR37","unstructured":"Folkh\u00e4lsomyndigheten. Arkiv f\u00f6r covid-19 veckorapporter. https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/covid-19-veckorapporter\/arkiv-for-covid-19-veckorapporter\/. Accessed 15 Feb 2025."},{"issue":"8","key":"748_CR38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147(8):573\u2013577","journal-title":"Ann Intern Med"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00748-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00748-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00748-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:52:59Z","timestamp":1743763979000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00748-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00748-6","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Swedish Ethical Review Authority (Dnr 2020-011955). Written informed consent was obtained at ICU admission, or if the patient was too severely ill, the consent was obtained as soon as possible. If the patient died before consent could be obtained, consent was presumed. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines were followed []. The study was registered on ClinicalTrials.gov Identifier: NCT04974775.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing, financial, or other interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}